Skip to main content
TipRanks
Go Ultimate75% OFF

Viridian Therapeutics (VRDN) Ownership - Who Owns Viridian Therapeutics?

1,573 Followers

Viridian Therapeutics (VRDN) Ownership Overview

  • 4.57% Insiders
  • 27.89% Mutual Funds
  • 13.43% Other Institutional Investors
  • 15.56% ETFs
  • 38.56% Public Companies and Individual Investors

The ownership structure of Viridian Therapeutics (VRDN) stock is a mix of institutional, retail, and individual investors. Approximately 56.88% of the company’s stock is owned by Institutional Investors, 4.57% is owned by Insiders, and 38.56% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 19, 2026Jennifer Tousignant$348,194
May 12, 2026Fairmount Funds Management Llc$19,999,990

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Perceptive Advisors Llc$7,854,097
Sep 30, 2026Antipodes Partners Ltd$13,775
Sep 30, 2026 $192,087,199

Top Shareholders

VRDN top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.9,329,150Institution8.22%279,501,334
Fairmount Funds Management Llc5,090,928Insider4.48%152,524,203
Peter Harwin5,090,928Institution4.48%152,524,203
Vanguard4,881,373Institution4.30%146,245,935
Vanguard Index Funds4,467,394Institution3.93%133,843,124
Ishares4,455,639Institution3.92%133,490,944
Fidelity Securities Fund3,136,580Institution2.76%93,971,937
Spdr2,937,682Institution2.59%88,012,953
Fidelity Select Portfolios2,808,304Institution2.47%84,136,788
Fidelity Advisor Series Vii2,542,464Institution2.24%76,172,221

Top Mutual Fund Holders

VRDN top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds4,467,394Institution3.93%133,843,124
Fidelity Securities Fund3,136,580Institution2.76%93,971,937
Fidelity Select Portfolios2,808,304Institution2.47%84,136,788
Fidelity Advisor Series Vii2,542,464Institution2.24%76,172,221
Fidelity Concord Street Trust2,062,635Institution1.82%61,796,545
T. Rowe Price Health Sciences Fund, Inc.1,447,742Institution1.27%43,374,350
Fidelity Rutland Square Trust Ii1,404,701Institution1.24%42,084,842
T. Rowe Price New Horizons Fund, Inc.1,351,696Institution1.19%40,496,812
Fidelity Salem Street Trust1,123,744Institution0.99%33,667,370
Fidelity Capital Trust1,089,196Institution0.96%32,632,312

Top ETF Holders

VRDN top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF2,659,076Institution2.34%65,599,405
iShares Russell 2000 ETF, IWM ETF2,617,328Institution2.30%82,288,792
SPDR S&P BIOTECH ETF, XBI ETF2,572,261Institution2.27%77,476,501
Vanguard Extended Market ETF, VXF ETF1,292,571Institution1.14%31,887,727
iShares Russell 2000 Value ETF, IWN ETF847,090Institution0.75%26,632,510
Dimensional U.S. Small Cap ETF, DFAS ETF683,038Institution0.60%20,573,105
Schwab U.S. Small-Cap ETF, SCHA ETF604,739Institution0.53%18,214,739
Vanguard Russell 2000 ETF, VTWO ETF590,538Institution0.52%14,568,572
iShares Micro-Cap ETF, IWC ETF307,488Institution0.27%9,667,423
U.S. Micro Cap Portfolio ETF, DFMC ETF285,532Institution0.25%6,612,921

FAQ

Who Owns Viridian Therapeutics (VRDN)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 56.88% of the company's stock is held by institutional investors, 4.57% is held by insiders, and 38.56% is held by public companies and individual investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 56.88% of Viridian Therapeutics (VRDN) stock is held by institutional investors: 27.89% by mutual funds, 15.56% by ETFs and 13.43% by other institutional investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 38.56% of Viridian Therapeutics (VRDN) stock is held by public companies and individual investors.
Who owns the most shares of Viridian Therapeutics (VRDN)?
BlackRock, Inc. owns the most shares of Viridian Therapeutics (VRDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.